On Thursday, Canadian Solar Inc. (NASDAQ:CSIQ)’s shares inclined 4.01% to $20.50.
Canadian Solar Inc. (CSIQ), one of the world’s largest solar power companies, recently declared that the Company has reached a long term product supply agreement with Vivint Solar (VSLR), a leading provider of distributed solar energy to residential and commercial customers in the United States. This contract, which allows for Canadian Solar to supply Vivint Solar with high efficiency CS6P polycrystalline modules for residential and commercial installations, will give the Company the ability to reach additional customers within these market segments and expand its consumer base.
Canadian Solar Inc., together with its auxiliaries, designs, develops, manufactures, and sells solar wafers, cells, and solar power products worldwide. The company operates in two segments, Module and Energy. Its products comprise various solar modules that are used in residential, commercial, and industrial solar power generation systems.
Calpine Corporation( NYSE:CPN)’s shares gained 0.50% to $15.93.
Zamir Rauf, Executive Vice President and Chief Financial Officer of Calpine Corporation (CPN), is planned to attend the Bank of America Merrill Lynch Power & Gas Leaders Conference in Boston on September 16, 2015. Mr. Rauf will take part in a panel talk aboution titled “Maximizing Shareholder Value in a Volatile Deregulated Market.” The panel is planned to start at 10:15 a.m. Eastern Time / 9:15 a.m. Central Time.
Separately, Mr. Rauf is planned to attend the Wolfe Power and Gas Leaders Conference in New York City on September 30, 2015, where he will take part in a panel talk aboution titled “Capital Discipline Stories.” The talk aboution is planned to start at 3:30 p.m. Eastern Time / 2:30 p.m. Central Time.
Calpine Corporation, a wholesale power generation company, owns and operates natural gas-fired and geothermal power plants in North America. It operates natural gas-fired combustion turbines and renewable geothermal conventional steam turbines.
At the end of Thursday’s trade, NetApp Inc. (NASDAQ:NTAP)‘s shares dipped -0.46% to $32.21.
NetApp, Inc. (NTAP) released new details about its NetApp Insight® 2015 technical conference, a one-of-a-kind education and networking experience taking place October 12 to 15 in Las Vegas and November 16 to 19 in Berlin.
The company is happy to declare that the guest speaker is Chris Anderson, CEO of 3D Robotics, a best-selling author, and a former Wired editor-in-chief. Chris is also the founder of DIY Drones, an aerial robotics community with more than 40,000 members. Chris will share his entrepreneurial journey and his perspective on how data and drones inspire us to change the world.
At NetApp Insight in Las Vegas, Attendee Appreciation night will rock to the sounds of Grammy Award winning Train at the Mandalay Bay Beach, sponsored by Cisco and Fujitsu.
NetApp, Inc. provides software, systems, and services to manage and store computer data worldwide. It offers Data ONTAP storage operating system that delivers integrated data protection, comprehensive data administration, and built-in software for virtualized, shared infrastructures, cloud computing, and mixed workload business applications; E-Series storage systems for storage area network workloads (SAN); all-flash arrays that deliver input/output operations per second and ultralow latency to drive speed, responsiveness, and value from the applications that control key business operations; and hybrid arrays for mainstream business applications.
VIVUS, Inc. (NASDAQ:VVUS), ended its Thursday’s trading session with 0.62% gain, and closed at $1.61.
Vivus, Inc., (VVUS) whose shares shot up right away at the market opening yesterday morning, to a daily high of $1.66, representing a 38% enhance from the previous close of $1.20, settled back down to close for the day at $1.35. Still, a noteworthy gain for an issue that has been battered and beaten down since 2012. Volume ratcheted up to nearly 13 million shares, against an average daily volume of less than 2 million. Vivus has gained more than 15% during the last five trading days, and is up over 17% for the past thirty trading days.
The bio-pharmaceutical firm is involved in the treatment of obesity and erectile dysfunction, with two sponsored, FDA approved drugs on the market: Qsymia (weight control) and STENDRA (sexual health).
Icahn Enterprises partner IEH Biopharma, LLC, has made a cash tender offer for all of VVUS outstanding Convertible Senior Notes, due 2020, at a price of $680 per $1,000 of principal amount, plus interest. The offer expires at 5:00pm EST 7 October 2015. Vivus, based in Mountain View, California, had no comment on the offer. Likewise, IEH offered neither specific follow-up comments nor a platform of reasoning behind the offer.
VIVUS, Inc., a biopharmaceutical company, develops and commercializes therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health in the United States and the European Union.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.